Overview
The actively managed fund invests primarily in high-yield corporate bonds selected using strict criteria, either denominated in EUR or hedged into EUR.
When selecting issuers of such bonds, particular attention is taken to spread investments across the various credit ratings.
Benefits
Investors profit from an actively managed portfolio with high return potential that is composed using strict criteria in terms of security and sector selection and credit quality.
Clients can particularly benefit from UBS's expertise in markets where transparency and access to information may be limited.
The fund represents an attractive addition to a portfolio, offering high return potential and broad risk diversification.
Risks
Depending on the credit quality, the default risk is higher in the case of high yield bonds than with investment grade corporate and government bonds. Changes in interest rates have an effect on the value of the portfolio. This requires corresponding risk tolerance and capacity. Sustainability risks are environmental, social or governance events or conditions that can have a material negative effect on the return, depending on the relevant sector, industry and company exposure. Sustainability risk: the risk arising from any environmental, social or governance events or conditions that, were they to occur, could cause a material negative impact on the value of the investment. All investments are subject to market fluctuations. Every fund has specific risks, which can significantly increase under unusual market conditions. The fund can use derivatives, which may result in additional risks (particularly counterparty risk). This Fund may not be appropriate for investors who plan to withdraw their money before the recommended holding period disclosed in the PRIIPs KID, if available for this share class.
Features
| Product category |
Bond High Yield |
| Product domicile |
Luxembourg
|
| Portfolio management |
UBS SA国际传谋 (UK) Ltd., London
|
| Fund management |
UBS SA国际传谋 (Europe) S.A., Luxembourg
|
| Custodian bank |
UBS Europe SE, Luxembourg Branch
|
| Representative for products established under foreign law |
UBS Fund Management (Switzerland) AG
|
| Day of inception |
June 26, 2024
|
| Currency of account |
EUR
|
| Close of financial year |
March 31
|
| SFDR Classification |
Art.8
|
| Issue / redemption |
daily
|
| Distribution |
Reinvestment
|
| Maturity |
Open end
|
| Ongoing costs p.a. |
0.61% p.a.
|
| Management fee |
0.46% p.a.
|
| Total expense ratio (TER) |
0.61% p.a.
|
| Minimum investment |
n.a.
|
| Reference Index / Benchmark |
ICE BofA EUR High Yield 3% Constrained Index
|
| Cut-Off Time |
15:00h(CET)
|
| Securities no. |
4734601
|
| ISIN |
LU1368322555
|
| Bloomberg Ticker |
ULEIA2A LX
|
Performance and Prices
Percentage growth
as of April 23, 2026
Cumulative
| EUR(%) | CHF(%) | USD(%) | |
| YTD | 0.51 | -0.87 | 0.22 |
| 1M | |||
| 3M | |||
| 6M | |||
| 1Y | |||
| 2Y | 6.25 | 5.35 | 20.51 |
| 3Y | |||
| 5Y | |||
| ø p.a.5Y |
Current data
| Net asset value | 23.04.2026 | EUR 112.76 |
| High - last 12 months | 26.02.2026 | EUR 113.57 |
| Low - last 12 months | 24.04.2025 | EUR 106.37 |
| Assets of the unit class in mn | 23.04.2026 | EUR 27.02 |
| Total product assets in mn | 23.04.2026 | EUR 3,489.71 |
| Option Adjusted Duration | 31.03.2026 | 3.90 |
Structures
By the 10 largest positions (in %, as of March 31, 2026)
|
|
|
| Nidda Healthcare Holding | 3.34 |
| Teva Pharmaceutical Industries Ltd | 2.80 |
| AROUNDTOWN S.A | 2.48 |
| Summer Bidco | 2.29 |
| CPI PROPERTY GROUP S.A | 2.24 |
| ZF North America Inc | 2.22 |
| Grifols | 1.96 |
| Pinnacle Bidco PLC | 1.94 |
| Cirsa Finance International | 1.84 |
| Altice | 1.56 |
Fees
Ongoing costs p.a.
0.6132%
Flat fee
0.5800%
Management fee p.a.
0.4600%
Distributions
No distributions. Continuous reinvestment of income.
Sales Authorisations
Literature
Brochures
Agreement / Prospectus
|
Document type
|
Document Language
|
|||
| Prospectus |
|
|
||
| Key Investor Information (KIID) |
|
|
|
|
| Key Information Document |
|
|
|
|
| Past performance |
|
|
|
|
| Previous performance scenario |
|
|
|
|
| Statutes / Management regulations |
|
|
||
| ESG Disclosure |
|
|||
| SFDR Pre-Contractual Annex |
|
Annual and semi-annual report (accounting on March 31)
|
Document type
|
Document Language
|
||
| Annual report |
|
|
|
| SFDR Periodic Report Annex |
|
|
|
| Semi-annual report |
|
|
|
Please wait for the requested content to load. If there is no response after several minutes, please reload the page or try again later.